| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9311824 | Urology | 2005 | 5 Pages |
Abstract
IOCS is a safe and effective blood management strategy for patients undergoing RRP. The risk of biochemical recurrence was not increased for those who received cell-salvaged blood. Concerns about spreading tumor cells by way of IOCS would seem unwarranted.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Alan M. Nieder, Adrienne J.K. Carmack, Paul D. Sved, Sandy S. Kim, Murugesan Manoharan, Mark S. Soloway,